Sfoglia per Autore
New inhibitors of salicylate synthase (MbtI) from m. tubercolosis: a promising strategy to antitubercular drugs
2016 S. Villa, A. Gelain, D. Barlocco, E. Pini, G. Beretta, M. Mori, L. Costantino, L.R. Chiarelli, M.R. Pasca, D. Bonanni, T. Tuccinardi, F. Meneghetti
Design and synthesis of novel furan-based MbtI inhibitors as potential antitubercular agents
2017 M. Mori, S. Villa, L.R. Chiarelli, A. Gelain, L. Costantino, T. Tuccinardi, M. Lapillo, F. Meneghetti
SANS study of lipid-based nanocarriers as inhaled drug delivery systems for anti-tuberculosis chemotherapy
2017 F. Meneghetti, C. Castellano, M. Mori, E. Leo, V. Iannuccelli, L. Costantino, F. Domenici
Full spectroscopic characterization of two crystal pseudopolymorphic forms of the antiandrogen cortexolone 17α-propionate for topic application
2017 P. Ferraboschi, M. Sala, R. Stradi, L. Ragonesi, C. Gagliardi, P. Lanzarotti, E..M. Ragg, M. Mori, F. Meneghetti
Diazabicyclo analogues of maraviroc : synthesis, modeling, NMR studies and antiviral activity
2017 L. Legnani, D. Colombo, A. Venuti, C. Pastori, L. Lopalco, L. Toma, M. Mori, G. Grazioso, S. Villa
Synthesis of novel furan-based antitubercolars potentially targeting the methionine aminopeptidases (MtMetAP1a)
2017 A. Gelain, S. Villa, M. Mori, L.R. Chiarelli, L. Costantino, T. Tuccinardi, F. Meneghetti
Design and synthesis of novel antituberculars targeting the salicylate synthase (MbtI)
2017 S. Villa, L.R. Chiarelli, M. Mori, A. Gelain, L. Costantino, D. Bonanni, T. Tuccinardi, F. Meneghetti
New synergic treatments for inhaled anti-TB therapy: a preliminary SANS study
2017 M. Mori, S. Villa, A. Gelain, G. Beretta, L.R. Chiarelli, L. Costantino, M.P.E. DI LEO, V. Iannuccelli, T. Tuccinardi, C. Castellano, F. Domenici, F. Meneghetti
Design, synthesis and biological evaluation of novel antitubercular agents targeting the Salycilate Syntase (MbtI).
2018 S. Villa, L.R. Chiarelli, M. Mori, D. Barlocco, A. Gelain, E. Pini, G. Mori, L. Costantino, T. Tuccinardi, F. Meneghetti
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI) : Preliminary Biological Evaluation and Molecular Modeling Studies
2018 E. Pini, G. Poli, T. Tuccinardi, L. Chiarelli, M. Mori, A. Gelain, L. Costantino, S. Villa, F. Meneghetti, D. Barlocco
Discovery and development of novel salicylate synthase (MbtI) Furanic inhibitors as antitubercular agents
2018 L.R. Chiarelli, M. Mori, D. Barlocco, G. Beretta, A. Gelain, E. Pini, M. Porcino, G. Mori, G. Stelitano, L. Costantino, M. Lapillo, D. Bonanni, G. Poli, T. Tuccinardi, S. Villa, F. Meneghetti
Application of chiral bi- and tetra-dentate bispidine-derived ligands in the copper(II)-catalyzed asymmetric Henry reaction
2018 A. Rossetti, S. Landoni, F. Meneghetti, C. Castellano, M. Mori, G. Colombo Dugoni, A. Sacchetti
A click chemistry approach to explore a new scaffold for potential antitubercular agents
2018 M. Mori, S. Villa, A. Gelain, L.R. Chiarelli, F. Meneghetti
Signal Transducer and Activator of Transcription Protein 3 (STAT3) : an Update on its Direct Inhibitors as Promising Anticancer Agents
2019 A. Gelain, M. Mori, F. Meneghetti, S. Villa
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity
2019 A. Gelain, M. Mori, F. Meneghetti, F. Porta, L. Basile, G. Marverti, A. Asai, M. Hyeraci, A.N. García-Argáez, L.D. Via, S. Guccione, S. Villa
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation
2019 E. Truzzi, F. Meneghetti, M. Mori, L. Costantino, V. Iannuccelli, E. Maretti, F. Domenici, C. Castellano, S. Rogers, A. Capocefalo, E. Leo
5,6-Dimethyl-1,3-dihydrobenzo[c][1,2,5]thiadiazole-2,2-dioxide as new STAT3 inhibitor
2019 S. Villa, M. Mori, F. Meneghetti, A. Pedretti, L. Regazzoni, D. Colombo, A. Asai, A. Gelain
Multi-target antitubercular drugs: identification of novel dual MbtI and MptpB inhibitors
2019 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
2019 D. Ehrsam, F. Porta, M. Mori, H.E.M.Z. Schwabedissen, L. Dalla Via, A.N. Garcia-Argaez, L. Basile, F. Meneghetti, S. Villa, A. Gelain
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MBTI from mycobacterium tuberculosis
2019 M. Mori, L. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti, S. Villa
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile